Section Arrow
Quote
RAPP.NASDAQ
- Rapport Therapeutics Inc.
Quotes are at least 15-min delayed:2025/01/11 11:25 EST
Last
 14.81
-1.88 (-11.26%)
Day High 
16.48 
Prev. Close
16.69 
1-M High
21.15 
Volume 
314.69K 
Bid
14.8
Ask
14.92
Day Low
14.3 
Open
16.48 
1-M Low
16.34 
Market Cap 
610.46M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 18.33 
20-SMA 18.61 
50-SMA 21.39 
52-W High 29.74 
52-W Low 16.34 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.96/-3.75
Enterprise Value
611.94M
Balance Sheet
Book Value Per Share
8.83
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed：2025/01/11 11:25 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational sciencehas elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.